2fmz: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="2fmz" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fmz, resolution 1.60Å" /> '''Carbonic anhydrase ...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2fmz.gif|left|200px]]<br />
[[Image:2fmz.gif|left|200px]]<br /><applet load="2fmz" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2fmz" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2fmz, resolution 1.60&Aring;" />
caption="2fmz, resolution 1.60&Aring;" />
'''Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII and XIV with L- and D- phenylalanine, structure with D-Phenylalanine.'''<br />
'''Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII and XIV with L- and D- phenylalanine, structure with D-Phenylalanine.'''<br />


==Overview==
==Overview==
Activation of six human brain carbonic anhydrases (hCAs, EC 4.2.1.1), hCA, I, II, IV, VA, VII, and XIV, with l-/d-phenylalanine was investigated, kinetically and by X-ray crystallography. l-Phe was a potent activator of, isozymes I, II, and XIV (K(A)s of 13-240 nM), a weaker activator of hCA VA, and VII (K(A)s of 9.8-10.9 microM), and a quite inefficient hCA IV, activator (K(A) of 52 microM). d-Phe showed good hCA II activatory, properties (K(A) of 35 nM), being a moderate hCA VA, VII, and XIV (K(A)s, of 4.6-9.7 microM) and a weak hCA I and IV activator (K(A)s of 63-86, microM). X-ray crystallography of the hCA II-l-Phe/d-Phe adducts showed, the activators to be anchored at the entrance of the active site, participating in numerous bonds and hydrophobic interactions with amino, acid residues His64, Thr200, Trp5, and Pro201. This is the first study, showing different binding modes of stereoisomeric activators within the, hCA II active site, with consequences for overall proton transfer, processes (rate-determining for the catalytic cycle). It also points out, differences of activation efficiency between various isozymes with, structurally related activators, exploitable for designing alternative, proton transfer pathways. CA activators may lead to the design of, pharmacologically useful derivatives for the enhancement of synaptic, efficacy, which may represent a conceptually new approach for the, treatment of Alzheimer's disease, aging, and other conditions in which, spatial learning and memory therapy must be enhanced. As the blood and, brain concentrations of l-Phe are quite variable (30-73 microM), activity, of some brain CAs may strongly be influenced by the level of activator(s), present in such tissues.
Activation of six human brain carbonic anhydrases (hCAs, EC 4.2.1.1), hCA I, II, IV, VA, VII, and XIV, with l-/d-phenylalanine was investigated kinetically and by X-ray crystallography. l-Phe was a potent activator of isozymes I, II, and XIV (K(A)s of 13-240 nM), a weaker activator of hCA VA and VII (K(A)s of 9.8-10.9 microM), and a quite inefficient hCA IV activator (K(A) of 52 microM). d-Phe showed good hCA II activatory properties (K(A) of 35 nM), being a moderate hCA VA, VII, and XIV (K(A)s of 4.6-9.7 microM) and a weak hCA I and IV activator (K(A)s of 63-86 microM). X-ray crystallography of the hCA II-l-Phe/d-Phe adducts showed the activators to be anchored at the entrance of the active site, participating in numerous bonds and hydrophobic interactions with amino acid residues His64, Thr200, Trp5, and Pro201. This is the first study showing different binding modes of stereoisomeric activators within the hCA II active site, with consequences for overall proton transfer processes (rate-determining for the catalytic cycle). It also points out differences of activation efficiency between various isozymes with structurally related activators, exploitable for designing alternative proton transfer pathways. CA activators may lead to the design of pharmacologically useful derivatives for the enhancement of synaptic efficacy, which may represent a conceptually new approach for the treatment of Alzheimer's disease, aging, and other conditions in which spatial learning and memory therapy must be enhanced. As the blood and brain concentrations of l-Phe are quite variable (30-73 microM), activity of some brain CAs may strongly be influenced by the level of activator(s) present in such tissues.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
2FMZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN, HG and DPN as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Carbonate_dehydratase Carbonate dehydratase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.2.1.1 4.2.1.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FMZ OCA].  
2FMZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=HG:'>HG</scene> and <scene name='pdbligand=DPN:'>DPN</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Carbonate_dehydratase Carbonate dehydratase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.2.1.1 4.2.1.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FMZ OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: ISPC, Israel.Structural.Proteomics.Center.]]
[[Category: ISPC, Israel Structural Proteomics Center.]]
[[Category: Scozzafava, A.]]
[[Category: Scozzafava, A.]]
[[Category: Supuran, C.T.]]
[[Category: Supuran, C T.]]
[[Category: Temperini, C.]]
[[Category: Temperini, C.]]
[[Category: Vullo, D.]]
[[Category: Vullo, D.]]
Line 33: Line 32:
[[Category: structural genomics]]
[[Category: structural genomics]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:07:55 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:23:01 2008''